Allakos Inc.

Home » Allakos Inc.

IPO

Allakos Inc.

We are a clinical stage biotechnology company developing AK002, our wholly owned monoclonal antibody, for the treatment of various eosinophil and mast cell related diseases.

Symbol

ALLK

Price Range
$15.00 - $17.00

Final Shares
6,000,000

Anticipated Date
TBD

Underwriters
Goldman Sachs & Co. LLC, Jefferies, William Blair

To view the prospectus for Allakos Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253